Schupp Christine J, Berbaum Kevin, Berbaum Michael, Lang Elvira V
Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, WCC 308, Boston, Massachusetts 02215, USA.
J Vasc Interv Radiol. 2005 Dec;16(12):1585-92. doi: 10.1097/01.RVI.0000185418.82287.72.
To assess how patients' underlying anxiety affects their experience of distress, use of resources, and responsiveness toward nonpharmacologic analgesia adjunct therapies during invasive procedures.
Two hundred thirty-six patients undergoing vascular and renal interventions, who had been randomized to receive during standard care treatment, structured empathic attention, or self-hypnotic relaxation, were divided into two groups: those with low state anxiety scores on the State-Trait Anxiety Inventory (STAI, scores < 43; n = 116) and those with high state anxiety scores (> or = 43; n = 120). All had access to patient-controlled analgesia with fentanyl and midazolam. Every 15 minutes during the procedure, patients rated their anxiety and pain on a scale of 0-10 (0, no pain/anxiety at all; 10, worst possible pain/anxiety). Effects were assessed by analysis of variance and repeated-measures analysis.
Patients with high state anxiety levels required significantly greater procedure time and medication. Empathic attention as well as hypnosis treatment reduced procedure time and medication use for all patients. These nonpharmacologic analgesia adjunct treatments also provided significantly better pain control than standard care for patients with low anxiety levels. Anxiety decreased over the time of the procedure; patients with high state anxiety levels experienced the most significant decreases in anxiety with nonpharmacologic adjuncts whereas patients with low state anxiety levels coped relatively well under all conditions.
Patients' state anxiety level is a predictor of trends in procedural pain and anxiety, need for medication, and procedure duration. Low and high state anxiety groups profit from the use of nonpharmacologic analgesia adjuncts but those with high state anxiety levels have the most to gain.
评估患者潜在的焦虑情绪如何影响其在侵入性操作过程中的痛苦体验、资源利用情况以及对非药物镇痛辅助治疗的反应。
236例接受血管和肾脏介入治疗的患者被随机分为三组,分别接受标准护理治疗、结构化共情关注或自我催眠放松。这些患者又被分为两组:状态-特质焦虑量表(STAI)状态焦虑得分低的患者(得分<43;n = 116)和状态焦虑得分高的患者(得分≥43;n = 120)。所有患者均可使用芬太尼和咪达唑仑进行患者自控镇痛。在操作过程中,每隔15分钟,患者用0至10分的量表对自己的焦虑和疼痛程度进行评分(0分表示完全没有疼痛/焦虑;10分表示可能出现的最严重疼痛/焦虑)。通过方差分析和重复测量分析评估效果。
状态焦虑水平高的患者需要显著更长的操作时间和更多的药物。共情关注以及催眠治疗减少了所有患者的操作时间和药物使用。对于低焦虑水平的患者,这些非药物镇痛辅助治疗在疼痛控制方面也明显优于标准护理。焦虑在操作过程中随时间下降;状态焦虑水平高的患者在使用非药物辅助治疗时焦虑下降最为显著,而状态焦虑水平低的患者在所有情况下应对相对较好。
患者的状态焦虑水平是操作过程中疼痛和焦虑趋势、药物需求以及操作持续时间的预测指标。低状态焦虑组和高状态焦虑组都能从使用非药物镇痛辅助治疗中获益,但高状态焦虑组获益最大。